Conference abstract
Serum-free expansion, harvest and preservation of mesenchymal stem cells from a scalable microcarrier process
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The use of animal-derived serum is common in MSC culture but has many drawbacks such as limited supply, lot-to-lot variability, possibility of pathogen transmission and reduced scope for process optimisation. These constraints have the potential to impact the development of a consistent large-scale process and therefore must be addressed. In this work, we have demonstrated the successful end-to-end production of MSCs from a potentially scalable serum-free process. Human MSCs have been expanded on fibronectin coated, non-porous plastic P-102L microcarriers (Solohill, USA) in 100 mL stirred spinner flasks at a density of 3x105 cells/mL in serum-free medium with monitoring of key metabolites. MSCs were successfully detached and separated from microcarriers using our recently-developed protocol with a post-harvest viability of 99.63 ? 0.03%, demonstrating full ISCT characterisation and maintaining MSC outgrowth and colony-forming potential. MSCs were held post-harvest for four hours in suspension to simulate a typical pooling time for a scaled expansion process and cryopreserved in a serum-free vehicle solution using our developed controlled-rate freezing process. Post-thaw viability was 75.8 ? 1.4% with a similar three hour attachment efficiency of 75.2 ? 13.1%, demonstrating successful MSC recovery and attachment. MSCs were able to form an F-Actin containing cytoskeleton following attachment and demonstrated five-fold expansion after seven days in culture post-thaw. This study has demonstrated for the first time that MSCs can be expanded, harvested, cryopreserved and recovered from a potentially scalable serum-free microcarrier process. Demonstrating the successful integration of multiple unit operations in a serum-free MSC production process from expansion through to cryopreservation provides an important pilot study in the development of an end-to-end MSC manufacturing process.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Thomas R J Heathman”
